Correlation Between Dividend and Big Pharma
Can any of the company-specific risk be diversified away by investing in both Dividend and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dividend and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dividend 15 Split and Big Pharma Split, you can compare the effects of market volatilities on Dividend and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dividend with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dividend and Big Pharma.
Diversification Opportunities for Dividend and Big Pharma
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dividend and Big is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Dividend 15 Split and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Dividend is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dividend 15 Split are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Dividend i.e., Dividend and Big Pharma go up and down completely randomly.
Pair Corralation between Dividend and Big Pharma
Assuming the 90 days horizon Dividend 15 Split is expected to generate 0.96 times more return on investment than Big Pharma. However, Dividend 15 Split is 1.05 times less risky than Big Pharma. It trades about 0.06 of its potential returns per unit of risk. Big Pharma Split is currently generating about -0.03 per unit of risk. If you would invest 615.00 in Dividend 15 Split on October 24, 2024 and sell it today you would earn a total of 6.00 from holding Dividend 15 Split or generate 0.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dividend 15 Split vs. Big Pharma Split
Performance |
| Timeline |
| Dividend 15 Split |
| Big Pharma Split |
Dividend and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dividend and Big Pharma
The main advantage of trading using opposite Dividend and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dividend position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.| Dividend vs. North American Financial | Dividend vs. Dividend Growth Split | Dividend vs. Dividend 15 Split | Dividend vs. Financial 15 Split |
| Big Pharma vs. Sustainable Power Infrastructure | Big Pharma vs. Global Dividend Growth | Big Pharma vs. Brompton Lifeco Split | Big Pharma vs. Prime Dividend Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |